XML 34 R21.htm IDEA: XBRL DOCUMENT v3.20.4
Earnings (Loss) Per Common Share
6 Months Ended
Dec. 31, 2020
Earnings (Loss) Per Common Share  
Earnings (Loss) Per Common Share

Note 14. Earnings (Loss) Per Common Share

A reconciliation of the Company’s basic and diluted earnings (loss) per common share was as follows:

Three Months Ended

December 31, 

(In thousands, except share and per share data)

    

2020

    

2019

Numerator:

Net income (loss)

 

$

(171,948)

 

$

5,084

Interest expense applicable to the Notes, net of tax

 

 

Amortization of debt issuance costs applicable to the Notes, net of tax

 

 

Adjusted “if-converted” net income (loss)

 

$

(171,948)

 

$

5,084

Denominator:

Basic weighted average common shares outstanding

 

39,443,441

 

38,605,052

Effect of potentially dilutive options and restricted stock awards

 

 

1,952,451

Effect of conversion of the Notes

 

 

Diluted weighted average common shares outstanding

 

39,443,441

 

40,557,503

Earnings (loss) per common share:

Basic

 

$

(4.36)

 

$

0.13

Diluted

 

$

(4.36)

 

$

0.13

Six Months Ended

December 31, 

(In thousands, except share and per share data)

    

2020

    

2019

Numerator:

Net loss

 

$

(178,447)

 

$

(7,073)

Interest expense applicable to the Notes, net of tax

 

 

Amortization of debt issuance costs applicable to the Notes, net of tax

 

 

Adjusted “if-converted” net loss

 

$

(178,447)

 

$

(7,073)

Denominator:

Basic weighted average common shares outstanding

 

39,257,211

 

38,457,159

Effect of potentially dilutive options and restricted stock awards

 

 

Effect of conversion of the Notes

 

 

Diluted weighted average common shares outstanding

 

39,257,211

 

38,457,159

Loss per common share:

Basic

 

$

(4.55)

 

$

(0.18)

Diluted

 

$

(4.55)

 

$

(0.18)

The number of anti-dilutive shares that have been excluded in the computation of diluted loss and earnings per share for the three months ended December 31, 2020 and 2019 were 8.1 million and 6.0 million, respectively. The number of anti-dilutive shares that have been excluded in the computation of diluted loss and earnings per share for the six months ended December 31, 2020 and 2019 were 8.1 million and 6.7 million, respectively. The effect of potentially dilutive shares was excluded from the calculation of diluted loss per share in the three and six months ended December 31, 2020 and the six months ended December 31, 2019 because the effect of including such securities would be anti-dilutive.